A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Bangladesh, Indonesia, Malaysia, Philippines, Sri Lanka and Vietnam (DiabCare Asia)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Hanoi, Vietnam
- Novo Nordisk Investigational Site
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- People with type 2 diabetes mellitus (DM) who are being treated, with any of the non-pharmacological or pharmacological options, at a particular centre for at least 1 year and who have visited the centre within the last 3-6 months
- Patients willing to sign informed consent form
Exclusion Criteria:
- Previous participation in this study
- Unable to comply with protocol requirements
- Confirmed or suspected pregnancy
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Subjects with diabetes mellitus (type 2)
|
Patients will fill out a questionnaire by interview.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Proportion of patients having HbA1c ((Glycosylated Haemoglobin) as measured during survey) less than 7%
Time Frame: Evaluated at the first visit (only one study visit)
|
Evaluated at the first visit (only one study visit)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Mean Fasting Plasma Glucose (FPG) of patients
Time Frame: Evaluated at the first visit (only one study visit)
|
Evaluated at the first visit (only one study visit)
|
|
Mean Postprandial Plasma Glucose (PPG) of patients
Time Frame: Evaluated at the first visit (only one study visit)
|
Evaluated at the first visit (only one study visit)
|
|
Mean HbA1c of patients
Time Frame: Evaluated at the first visit (only one study visit)
|
Evaluated at the first visit (only one study visit)
|
|
Proportion of patients having dyslipidemia
Time Frame: Evaluated at the first visit (only one study visit)
|
Evaluated at the first visit (only one study visit)
|
|
Proportion of patients having hypertension
Time Frame: Evaluated at the first visit (only one study visit)
|
Evaluated at the first visit (only one study visit)
|
|
Proportion of patients having cardiovascular complications
Time Frame: Evaluated at the first visit (only one study visit)
|
Evaluated at the first visit (only one study visit)
|
|
Proportion of patients having peripheral vascular disease
Time Frame: Evaluated at the first visit (only one study visit)
|
Evaluated at the first visit (only one study visit)
|
|
Proportion of patients having diabetic nephropathy
Time Frame: Evaluated at the first visit (only one study visit)
|
Evaluated at the first visit (only one study visit)
|
|
Proportion of patients having diabetic eye complications
Time Frame: Evaluated at the first visit (only one study visit)
|
Evaluated at the first visit (only one study visit)
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
General Publications
- Nguyen KT, Diep BTT, Nguyen VKD, Lam HV, Tran KQ, Tran NQ. A cross-sectional study to evaluate diabetes management, control and complications in 1631 patients with type 2 diabetes mellitus in Vietnam (DiabCare Asia). Int J Diabetes Dev Ctries 2019 [Epub ahead of print] DOI: 10.1007/s13410-019-00755-w
Helpful Links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- INS-4069
- U1111-1137-2575 (OTHER: WHO)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.